P53 as a Target for Cancer Vaccines: Recombinant Canarypox Virus Vectors Expressing P53 Protect Mice Against Lethal Tumor Cell Challenge.
Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.93.10.4781
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 14, 1996
Authors
Publisher
Proceedings of the National Academy of Sciences